Quantcast
Last updated on April 17, 2014 at 16:07 EDT

Latest European Association for the Study of Diabetes Stories

2014-01-31 10:50:31

New research published today shows that depression and impulse control disorders (eating disorders in particular) are independently associated with diabetes diagnosis, after adjustment for presence of other mental disorders. The research, published in Diabetologia (the journal of The European Association for the Study of Diabetes), supports the focus on depression as an independent risk factor for diabetes, but also suggests this focus should be extended to impulse control disorders. The...

2013-11-13 08:30:29

BRUSSELS, November 13, 2013 /PRNewswire/ -- Professor Jean-Philippe Assal was presented with the 2013 IDF Europe Prize in Diabetes for Long-Standing Achievement today at an award ceremony at the European Parliament in Brussels. The prize was handed over in recognition of his ground-breaking work in the field of therapeutic patient education. A diabetologist and endocrinologist by training, Professor Jean-Philippe Assal was convinced early on that the education of people...

2013-11-12 10:44:07

A study of more than 60 000 women has shown that higher overall acidity of the diet, regardless of the individual foods making up that diet, increases the risk of type 2 diabetes. The study, the first large prospective study to demonstrate these findings, is published in Diabetologia, the journal of the European Association for the Study of Diabetes (EASD), and is by Dr Guy Fagherazzi and Dr Françoise Clavel-Chapelon, Center for Research in Epidemiology and Population Health, INSERM, Paris,...

2013-09-26 08:27:14

Improvements in several indicators of diabetes management, including perceptions about hyperglycaemia and weight, observed for investigational GLP-1 receptor agonist BARCELONA, Spain, Sept. 26, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive patient-reported health outcomes from a Phase III clinical trial of dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor agonist being studied as a once-weekly treatment for type 2 diabetes....

2013-09-24 08:29:46

Two pooled analyses of data from clinical trials in adults with type 2 diabetes, including the elderly with normal renal function to severe renal impairment, found similar incidence of adverse events for linagliptin compared with placebo RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 24, 2013 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (Lilly; NYSE: LLY) today announced results from two post-hoc, pooled analyses of data from placebo-controlled clinical trials, which examined the...

2013-09-17 08:31:21

Presentations at EASD to include safety and efficacy data for the Diabetes Alliance compounds RIDGEFIELD, Conn. and INDIANAPOLIS, Sept. 17, 2013 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (Lilly; NYSE: LLY) today announced they will feature five oral and 12 poster presentations for linagliptin and the investigational compound empagliflozin(^) at the 49(th) Annual Meeting of the European Association for the Study of Diabetes (EASD), which will take place in Barcelona from...

2013-06-26 16:51:32

Both the UK and Canada have experienced huge falls in diabetes-related mortality since the mid-1990s, with the result that the gap in mortality risk between those with and without diabetes has narrowed substantially. The findings are in new research published in Diabetologia, the Journal of the European Association for the Study of Diabetes (EASD), and written by Dr Marcus Lind, Sahlgrenska Academy, University of Gothenburg, Sweden and colleagues. A previous review of studied investigated...

2012-12-06 12:28:07

BOSTON, Dec. 6, 2012 /PRNewswire/ -- The T1D Exchange, a not-for-profit organization accelerating the discovery of new approaches to type 1 diabetes research and treatment, announced today that Dana Ball has joined the organization as Chief Executive Officer. In his new role, Mr. Ball will oversee the integration and expansion of the T1D Exchange's multiple components, including the clinical registry, biobank and Glu, an online social network for people with type 1 diabetes. Mr. Ball...

2012-10-04 02:23:08

SAN DIEGO, Oct. 4, 2012 /PRNewswire/ -- Profil Institute for Clinical Research, Inc., a specialized clinical research institute optimizing early phase diabetes, obesity and cardiometabolic drug development, announced today that Prof. Andrew J Krentz M.D., Senior Director of Scientific Services, has been appointed Editor-in-Chief of the online journal Cardiovascular Endocrinology (www.cardiovascularendocrinology.com). The journal was officially launched this week at the European Association...

2012-10-03 02:28:09

HAYWARD, Calif., Oct. 3, 2012 /PRNewswire/ -- Intarcia Therapeutics, Inc. announced the presentation of an analysis of phase 2 clinical study results for ITCA 650 (continuous subcutaneous delivery of exenatide) for the treatment of type 2 diabetes at the 48th Annual Meeting of the European Association for the Study of Diabetes (EASD) in Berlin Germany on Wednesday, October 3, by Dr. Robert R. Henry, MD, Chief, Section of Diabetes, Endocrinology and Metabolism at the University of California,...